Iron Deficiency Anemia Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)

Iron deficiency anemia market is anticipated to grow at a considerable CAGR of 6.8% during the forecast period. The increasing number of cases associated with haemodilution in pregnancy across the globe is one of the prime factors affecting and driving the market for iron deficiency anemia. Haemodilution generally occurs during pregnancy and the most common causes of anemia during pregnancy are iron deficiency and folate acid deficiency. Additionally, the changes in lifestyle which are more in developed and developing countries, are resulting in irregular BMI, and an increase in abnormal weight which in turn is disturbing the physiology of a pregnant woman impacting the market.

Moreover, to gain on the opportunity key players operating in the global iron deficiency anemia market had been adopting strategies such as new launches to achieve major market share. For instance, in July 2021, one of the divisions of Novartis AG that is Sandoz had introduced generic Ferumoxytol in the US which is an intravenous medication used for the purpose of treatment of iron deficiency anemia (IDA). Through this launch, the company would continue to build its hospital and clinic portfolio along with offering access to affordable generic medicines.

To Request a Sample of our Report on Iron Deficiency Anemia Market: https://www.omrglobal.com/request-sample/iron-deficiency-anemia-market

Market Coverage

• The market number available for - 2022-2030

• Base year- 2022

• Forecast period- 2023-2030

Segment Covered-

· By Therapy Type

· By End-User

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- AMAG Pharmaceuticals, Bayer AG, Novartis AG, Sanofi, and Pieris Pharmaceuticals, Inc.

A full Report of Iron Deficiency Anemia Market is Available @ https://www.omrglobal.com/industry-reports/iron-deficiency-anemia-market

Iron Deficiency Anemia Market Report Segment

By Therapy Type

• Intravenous Iron Therapy

• Oral Iron Therapy

• Red Blood Cell Transfusion

• Others

By End-User

• Hospitals & Clinics

• Home Healthcare

Iron Deficiency Anemia Market Report Segment by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Company Profiles

· Akebia Therapeutics, Inc.

· AMAG Pharmaceuticals

· Bayer AG

· Fe3 Medical Inc.

· Iron4u Aps

· LUITPOLD PHARMACEUTICALS, INC.

· Novartis AG

· Pieris Pharmaceuticals, Inc.

· Pharmacosmos A/S.

· Renibus Therapeutics Inc.

· Rockwell Medical, Inc.

· Sanofi

· Shield Therapeutics plc

· Vifor Pharma Ltd.

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/iron-deficiency-anemia-market

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.